期刊文献+

经相同肝实质细胞体积分摊的血清HBsAg水平与肝组织病理进展相关而与HBeAg状态无关 被引量:4

HBsAg Levels Normalized to the Same Hepatic Parenchyma Cell Volume Is Correlated with Pathological Progression but Not HBeAg Status
下载PDF
导出
摘要 【目的】回顾性研究HBeAg阳性与HBeAg阴性慢性乙型病毒性肝炎之间,血清HBsAg的水平以及经相同肝实质细胞体积(肝细胞数量)分摊计算后血清HBsAg水平的异同。【方法】选取中山大学附属第三医院168例因病情需要而进行了肝穿刺活检及HBsAg定量检测的慢乙肝患者为研究对象。比较其HBeAg阳性与HBeAg阴性之间的血清HBsAg水平,以及经相同肝实质细胞体积(肝细胞数量)分摊计算后的血清HBsAg水平。【结果】血清HBsAg水平在HBeAg阳性和HBeAg阴性慢乙肝患者之间的差异有统计学意义(P=0.028);而经相同肝实质细胞体积(肝细胞数量)分摊计算后的血清HBsAg水平,在HBeAg阳性和HBeAg阴性慢乙肝之间的差异无统计学意义(P=0.073)。无论HBeAg阳性或HBeAg阴性,其血清HBsAg水平的高低与肝组织炎症程度无相关性(HBeAg阳性:rs=0.020,P=0.876;HBeAg阴性:rs=0.037,P=0.711);与肝纤维化进展无相关性(HBeAg阳性:rs=0.087,P=0.488;HBeAg阴性:rs=0.144,P=0.148)。而经相同肝实质细胞体积(肝细胞数量)分摊计算后的血清HBsAg水平与肝组织炎症程度呈正相关(HBeAg阳性:rs=0.309,P=0.012;HBeAg阴性:rs=0.389,P<0.001);与肝纤维化进展呈正相关性(HBeAg阳性:rs=0.490,P<0.001;HBeAg阴性:rs=0.599,P<0.001)。【结论】经相同肝实质细胞体积(肝细胞数量)分摊计算后的血清HBsAg,而非血清HBsAg水平,在HBeAg阳性或HBeAg阴性慢乙肝之间无差异;且均与肝组织炎症分级和纤维化分期程度呈正相关。 【Objective】To study retrospectively the serum hepatitis B surface antigen(HBsAg)and HBsAg normalized to the same hepatic parenchyma cell volume(HPCV),namely ,the same hepatic cell quantities,between HBeAg positive and HBeAg-negative chronic hepatitis B(CHB).【Methods】A total of 168 CHB patients who had undergone liver biopsy and test of serum HBsAg levels due to their disease in the Third Affiliated Hospital of SunYat-sen University were selected as the study subjects. The serum HBsAg levels,as well as HBsAg levels normalized to HPCV(hepatic cell quantities)were compared between HBeAg-positive and HBeAg- negative CHB,respectively.【Results】There was statistically significant difference in serum HBsAg levels between HBeAg-positive and HBeAg-negative CHB(P = 0.028), while there was no statistical difference in HBsAg normalized to HPCV(P = 0.073). There were no correlations between serum HBsAg and liver inflammation grades(HBeAg-positive:rs = 0.020,P = 0.876 & HBeAg-negative:rs = 0.037,P =0.711). Similarly,there were no correlations between HBsAg and hepatic fibrosis stages(HBeAg-positive:rs = 0.087, P = 0.488 & HBeAg-negative:rs = 0.144,P = 0.148). Nevertheless,statistically significant positive correlations were shown between HBsAg normalized to HPCV and liver inflammation grades(HBeAg-positive:rs = 0.309,P = 0.012 & HBeAg-negative:rs = 0.389,P < 0.001). Similarly,the HBsAg normalized to HPCV and hepatic fibrosis stages were shown to be statistically significantly correlated(HBeAg- positive:rs = 0.490,P < 0.001 & HBeAg-negative:rs = 0.599, P < 0.001).【Conclusions】Serum HBsAg normalized to HPCV but not HBsAg levels,is correlated with liver inflammation grades as well as hepatic fibrosis stages positively in both HBeAg-positive and HBeAg-negative CHB. But there is no difference in serum HBsAg levels normalized to HPCV between HBeAg-positive and HBeAg-negative CHB.
作者 谭雷 吴涛 吕艳 王韦力 任杰 郑荣琴 吴泽倩 TAN Lei;WU Tao;LV Yan;WANG Wei-li;REN Jie;ZHENGRong-qin;WU Ze-qian(Department of Ultrasound,The Third Affiliated Hospital of Sun Yat-sen University,Guangzhou 510630,China;Department of Infectious Diseases,The Third Affiliated Hospital of Sun Yat-sen University,Guangzhou 510630,China)
出处 《中山大学学报(医学版)》 CAS CSCD 北大核心 2019年第5期747-753,共7页 Journal of Sun Yat-Sen University:Medical Sciences
基金 国家重点研发计划(2017YFC0112000) 广州市科技计划项目(201704020164)
关键词 血清HBSAG 肝实质细胞体积(肝细胞数量) 肝组织炎症分级 肝纤维化分期 serum HBsAg levels hepatic parenchyma cell volume (hepatic cell quantities) liver inflammation grades hepatic fibrosis stages
  • 相关文献

参考文献4

二级参考文献37

  • 1Meetings[J].World Journal of Gastroenterology,2010,16(2). 被引量:28
  • 2BinGao.Cytokines,STATs and Liver Disease[J].Cellular & Molecular Immunology,2005,2(2):92-100. 被引量:30
  • 3Joachim Lupberger,Eberhard Hildt.Hepatitis B virus-induced oncogenesis[J].World Journal of Gastroenterology,2007,13(1):74-81. 被引量:57
  • 4Anis Khan,Mohammed A. Al Balwi,Yasuhito Tanaka,Ali Hajeer,Faisal M. Sanai,Ibrahim Al Abdulkarim,Latifah Al Ayyar,Motasim Badri,Dib Saudi,Waleed Tamimi,Masashi Mizokami,Bandar Al Knawy.Novel point mutations and mutational complexes in the enhancer II, core promoter and precore regions of hepatitis B virus genotype D1 associated with hepatocellular carcinoma in Saudi Arabia[J].Int J Cancer.2013(12)
  • 5Rohit Loomba,Jessica Liu,Hwai–I. Yang,Mei–Hsuan Lee,Sheng–Nan Lu,Li–Yu Wang,Uchenna H. Iloeje,San–Lin You,David Brenner,Chien–Jen Chen.Synergistic Effects of Family History of Hepatocellular Carcinoma and Hepatitis B Virus Infection on Risk for Incident Hepatocellular Carcinoma[J].Clinical Gastroenterology and Hepatology.2013
  • 6Chun-Jen Liu,Jia-Horng Kao.Global Perspective on the Natural History of Chronic Hepatitis B: Role of Hepatitis B Virus Genotypes A to J[J].Semin Liver Dis.2013(02)
  • 7Chun-Hui Yan,Cheng-Yu Zhao,Hai Ding,Ya-Qin Peng,Peng-Yuan Jin,Ling Yan,Hui Zhuang,Tong Li.Hepatitis B virus basal core promoter mutations A1762T/G1764A are associated with genotype C and a low serum HBsAg level in chronically-infected HBeAg-positive Chinese patients[J].Antiviral Research.2012(2)
  • 8H. Lyu,D. Lee,Y.‐H. Chung,J. A. Kim,J.‐H. Lee,Y.‐J. Jin,W. Park,P. Mathews,E. Jaffee,L. Zheng,E. Yu,Y. J. Lee.Synergistic Effects of A1896, T1653 and T1762/A1764 Mutations in Genotype C2 Hepatitis B Virus on Development of Hepatocellular Carcinoma[J].J Viral Hepat.2012(3)
  • 9Uchenna H Iloeje,Hwai‐I Yang,Chien‐Jen Chen.Natural history of chronic hepatitis B : what exactly has REVEAL Revealed?[J].Liver Int.2012(9)
  • 10Hui Nie,Alison A. Evans,W. Thomas London,Timothy M. Block,Xiangdong David Ren.Quantitative dynamics of hepatitis B basal core promoter and precore mutants before and after HBeAg seroconversion[J].Journal of Hepatology.2011(4)

共引文献45

同被引文献52

引证文献4

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部